RT Journal Article
T1 Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
A1 Kardas, Przemysław
A1 Bago, Martina
A1 Barnestein-Fonseca, Pilar
A1 Garuolienė, Kristina
A1 Granas, Anne Gerd
A1 Gregório, João
A1 Hadžiabdić, Maja Ortner
A1 Kostalova, Barbora
A1 Leiva-Fernández, Francisca
A1 Lewek, Pawel
A1 Mala-Ladova, Katerina
A1 Schneider, Marie Paule
A1 van Boven, Job F M
A1 Volmer, Daisy
A1 Ziampara, Ioli
A1 Ágh, Tamás
K1 Europe
K1 drugs
K1 healthcare systems
K1 interventions
K1 medication adherence
K1 non-adherence
K1 persistence
K1 reimbursement
AB Background: Medication non-adherence jeopardises the effectiveness of chronic therapies and negatively affects financial sustainability of healthcare systems. Available medication adherence-enhancing interventions (MAEIs) are utilised infrequently, and even more rarely reimbursed. The aim of this paper was to review reimbursed MAEIs across selected European countries. Methods: Data on reimbursed MAEIs were collected from European countries at the ENABLE Cost Action expert meeting in September 2021. The identified MAEIs were analysed and clustered according to their characteristics, direct vs. indirect relation to adherence, and the targeted adherence phase. Results: Out of 12 contributing countries, 10 reported reimbursed MAEIs, 28 in total, of which 20 were identified as MAEIs targeting adherence directly. Reimbursed MAEIs were most often performed by either doctors (n = 6), nurses (n = 6), or pharmacists (n = 3). The most common types of MAEIs were education (n = 6), medication regimen management (n = 5), and adherence monitoring feedback (n = 4). Only seven reimbursed MAEIs were technology-mediated, whereas 11 addressed two interlinked phases of medication adherence, i.e., implementation and persistence. Conclusion: Our review highlights the scarcity of reimbursed MAEIs across the selected European countries, and calls for their more frequent use and reimbursement.
SN 1663-9812
YR 2022
FD 2022-08-11
LK http://hdl.handle.net/10668/20710
UL http://hdl.handle.net/10668/20710
LA en
DS RISalud
RD Jul 29, 2025